Sotalol, a beta-adrenoceptor blocking drug, was administered to 6 healthy pregnant volunteers between 32–36 weeks gestation and when at least 6 weeks post-partum. On both occasions, each volunteer was given sotalol 100 mg intravenously and 400 mg orally in randomised order with at least a 1 week washout period between. Plasma samples were analysed for sotalol using a fluorometric method and the pharmacokinetic profiles investigated. The systemic clearance of sotalol was significantly greater in the antenatal period (2.4±0.3 ml/min/kg) than in the post-natal phase (1.5±0.1 ml/min/kg). The apparent volume of distribution was similar in the two periods: the elimination half-life was 6.6±0.6h ante-natally and 9.3±0.7h post-natally after intravenous drug but the trend for faster elimination was not significant. The elimination half-life after oral administration (about 10h) and bioavailability (about 90%) were not altered significantly by pregnancy. It is suggested that the more rapid clearance of sotalol in pregnancy may be due to increases in renal plasma flow and glomerular filtration rate.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Anttila M, Arstila M, Pfeffer M, Tikkanen R, Vallinkoski V, Sundquist H (1976) Human pharmacokinetics of sotalol. Acta Pharmacol Toxicol 39: 118–128
Berglund G, Descamps R, Thomas JA (1980) Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency. Eur J Clin Pharmacol 18: 321–326
Blair AD, Burgess ED, Maxwell BM, Cutler RE (1981) Sotalol kinetics in renal insufficiency. Clin Pharmacol Ther 29: 457–463
Brown HC, Carruthers SG, Kelly JG, McDevitt DG, Shanks RG (1976) Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol 9: 367–372
Davison JM, Hytten FE (1974) Glomerular filtration during and after pregnancy. Br J Obstet Gynaecol 81: 588–595
Dunlop W (1976) Investigations into the influence of posture on renal plasma flow and glomerular filtration rate during late pregnancy. Br J Obstet Gynaecol 83: 17–23
Frishman W (1979) Clinical pharmacology of the new beta-adrenergic blocking drugs. Part I. Pharmacodynamic and pharmacokinetic properties. Am Heart J 97: 663–670
Garrett ER, Schnelle K (1971) Separation and spectrofluorometric assay of beta-adrenergic blocker sotalol from blood and urine. J Pharm Sci 60: 833–839
Ishizaki T, Tawara K, Oriuchi K (1977) Project planning and evaluation of pharmacokinetics extrapolating from animal to man: A study using a beta-blocker, sotalol, as a model marker. Adv Clin Pharmacol 13: 265–282
Krauer B, Krauer F, Hytten FE (1980) Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Pharmacol Ther 10: 301–328
Lewis PJ, DeSwiet M, Chamberlain GVP, Bulpitt CJ (1977) The management of hypertension in the pregnant woman. In: Lewis PJ (ed) Therapeutic problems in pregnancy. MTP Press. Lancaster, pp 53–62
McDevitt DG, Shanks RG (1977) Evaluation of once daily sotalol administration in man. Br J Clin Pharmacol 4: 153–156
O'Hare MF, Murnaghan GA, Russell CJ, Leahey WJ, Varma MPS, McDevitt DG (1980) Sotalol as a hypotensive agent in pregnancy. Br J Obstet Gynaecol 87: 814–820
Philipson A (1977) Pharmacokinetics of ampicillin during pregnancy. J Infect Dis 136: 370–376
Sundquist H (1980) Basic review and comparison of beta-blocker pharmacokinetics. Curr Ther Res 28: 385–445
Tjandramaga TB, Thomas J, Verbeeck R, Verbesselt R, Verbenckmaens R, DeSchepper PJ (1976) The effect of endstage renal failure and haemodialysis of the elimination kinetics of sotalol. Br J Clin Pharmacol 3: 259–265
Truelove JF, Van Petten GR, Willes RF (1973) Action of several β-adrenoceptor blocking drugs in the pregnant sheep and fetus. Br J Pharmacol 47: 161–171
About this article
Cite this article
O'Hare, M.F., Leahey, W., Murnaghan, G.A. et al. Pharmacokinetics of sotalol during pregnancy. Eur J Clin Pharmacol 24, 521–524 (1983). https://doi.org/10.1007/BF00609896
- beta-adrenoceptor antagonist